What the JCA means for market access in Finland?

Interview of Herbert Altmann, PhD, VP, Market Access & Healthcare Consulting Europe at PharmaLex. Finland, and the Nordics in general, have key selling points that could be highlighted to keep the region front and center. These include unique opportunities to make use of real-world data and biobanks for real-world evidence purposes.